Aster DM Healthcare Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 27, 2025, 1:16 am

Market Cap	25,238 Cr.
Current Price	505
High / Low	535/311
Stock P/E	87.2
Book Value	68.8
Dividend Yield	0.79 %
ROCE	4.48 %
ROE	3.13 %
Face Value	10.0
PEG Ratio	0.84

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Aster DM Healthcare Ltd

Competitors of Aster DM Healthcare Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NG Industries Ltd	53.6 Cr.	160	206/145	4.42	124	2.19 %	6.50 %	5.63 %	10.0
Global Longlife Hospital and Research Ltd	23.6 Cr.	22.5	46.4/18.3		25.9	0.00 %	2.51 %	4.72 %	10.0
Gian Lifecare Ltd	17.0 Cr.	16.4	27.0/12.1	4.15	19.2	0.00 %	29.2 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	143 Cr.	76.4	98.7/51.0	186	15.9	55.6 %	3.29 %	9.12 %	10.0
Family Care Hospitals Ltd	25.7 Cr.	4.75	9.50/3.40	0.67	2.67	0.00 %	15.4 %	24.1 %	10.0
Industry Average	23,910.57 Cr	708.00		57.88	87.89	2.67%	12.26%	11.94%	9.08

All Competitor Stocks of Aster DM Healthcare Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	2,650	2,728	2,662	2,816	3,192	807	841	929	955	974	1,002	1,086	1,050
Expenses	2,252	2,267	2,370	2,498	2,743	687	722	787	805	817	841	869	864
Operating Profit	397	460	292	319	449	120	119	142	149	156	161	217	186
OPM %	15%	17%	11%	11%	14%	15%	14%	15%	16%	16%	16%	20%	18%
Other Income	12	22	37	18	10	149	-17	-64	153	-40	5,120	35	9
Interest	67	62	69	77	87	25	25	30	25	30	29	31	31
Depreciation	161	170	175	189	198	54	51	54	57	58	60	62	62
Profit before tax	181	250	85	71	173	190	26	-7	220	28	5,191	159	102
Tax %	7%	2%	6%	23%	8%	4%	24%	120%	5%	108%	1%	33%	37%
Net Profit	168	246	80	54	159	183	20	-15	209	-2	5,152	106	64
EPS in Rs	2.97	4.53	1.37	0.93	2.79	3.42	0.10	-0.62	3.59	-0.48	103.00	1.94	1.14

Last Updated: March 3, 2025, 5:29 pm

Below is a detailed analysis of the quarterly data for Aster DM Healthcare Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 1,050.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,086.00 Cr. (Sep 2024) to 1,050.00 Cr., marking a decrease of 36.00 Cr..
For Expenses, as of Dec 2024, the value is 864.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 869.00 Cr. (Sep 2024) to 864.00 Cr., marking a decrease of 5.00 Cr..
For Operating Profit, as of Dec 2024, the value is 186.00 Cr.. The value appears to be declining and may need further review. It has decreased from 217.00 Cr. (Sep 2024) to 186.00 Cr., marking a decrease of 31.00 Cr..
For OPM %, as of Dec 2024, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Sep 2024) to 18.00%, marking a decrease of 2.00%.
For Other Income, as of Dec 2024, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Sep 2024) to 9.00 Cr., marking a decrease of 26.00 Cr..
For Interest, as of Dec 2024, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 31.00 Cr..
For Depreciation, as of Dec 2024, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 62.00 Cr..
For Profit before tax, as of Dec 2024, the value is 102.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Sep 2024) to 102.00 Cr., marking a decrease of 57.00 Cr..
For Tax %, as of Dec 2024, the value is 37.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Sep 2024) to 37.00%, marking an increase of 4.00%.
For Net Profit, as of Dec 2024, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 106.00 Cr. (Sep 2024) to 64.00 Cr., marking a decrease of 42.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 1.14. The value appears to be declining and may need further review. It has decreased from 1.94 (Sep 2024) to 1.14, marking a decrease of 0.80.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:12 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,922	2,871	3,876	5,250	5,931	6,721	7,963	8,652	8,608	10,253	2,994	3,699	4,112
Expenses	1,660	2,421	3,370	4,805	5,582	6,089	6,886	7,187	7,506	8,720	2,547	3,124	3,392
Operating Profit	261	451	506	445	349	632	1,077	1,465	1,103	1,533	447	575	720
OPM %	14%	16%	13%	8%	6%	9%	14%	17%	13%	15%	15%	16%	18%
Other Income	11	19	23	25	453	177	-155	-158	53	51	353	32	5,125
Interest	45	48	79	189	371	204	205	391	334	307	96	119	121
Depreciation	76	111	144	243	322	298	306	586	618	641	192	220	243
Profit before tax	151	310	306	38	108	308	410	330	205	637	511	268	5,480
Tax %	4%	9%	11%	78%	10%	8%	10%	5%	13%	6%	7%	21%
Net Profit	149	284	272	8	98	282	367	315	178	601	475	212	5,320
EPS in Rs	7.26	4.69	7.00	0.20	2.52	5.32	6.59	5.54	2.96	10.53	8.51	2.59	105.60
Dividend Payout %	0%	35%	0%	0%	0%	0%	0%	0%	0%	0%	0%	77%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	90.60%	-4.23%	-97.06%	1125.00%	187.76%	30.14%	-14.17%	-43.49%	237.64%	-20.97%	-55.37%
Change in YoY Net Profit Growth (%)	0.00%	-94.83%	-92.83%	1222.06%	-937.24%	-157.61%	-44.31%	-29.32%	281.13%	-258.61%	-34.40%

Aster DM Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	3%
5 Years:	-14%
3 Years:	-25%
TTM:	16%

Compounded Profit Growth
10 Years:	-3%
5 Years:	-23%
3 Years:	-4%
TTM:	74%

Stock Price CAGR
10 Years:	%
5 Years:	39%
3 Years:	39%
1 Year:	44%

Return on Equity
10 Years:	9%
5 Years:	9%
3 Years:	9%
Last Year:	3%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:40 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	125	375	389	403	403	505	505	497	497	500	500	500	500
Reserves	654	536	1,096	17	1,472	2,327	2,709	2,775	2,875	3,080	3,574	3,686	2,936
Borrowings	505	886	1,091	3,321	2,758	2,352	2,788	5,605	4,804	5,282	6,075	1,758	1,940
Other Liabilities	856	1,097	1,834	2,003	2,171	2,296	2,926	3,528	3,444	3,661	4,687	12,039	1,312
Total Liabilities	2,140	2,894	4,409	5,743	6,804	7,479	8,928	12,405	11,620	12,521	14,836	17,983	6,688
Fixed Assets	872	1,087	2,237	2,507	3,520	3,738	4,289	7,124	6,749	7,009	9,052	3,175	3,867
CWIP	185	357	197	358	290	402	550	736	934	998	279	170	231
Investments	6	7	3	39	32	38	22	34	63	45	80	17	24
Other Assets	1,077	1,442	1,972	2,839	2,962	3,302	4,067	4,511	3,874	4,470	5,425	14,620	2,567
Total Assets	2,140	2,894	4,409	5,743	6,804	7,479	8,928	12,405	11,620	12,521	14,836	17,983	6,688

Below is a detailed analysis of the balance sheet data for Aster DM Healthcare Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹500.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 500.00 Cr..
For Reserves, as of Sep 2024, the value is ₹2,936.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,686.00 Cr. (Mar 2024) to ₹2,936.00 Cr., marking a decrease of 750.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹1,940.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,758.00 Cr. (Mar 2024) to ₹1,940.00 Cr., marking an increase of 182.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,312.00 Cr.. The value appears to be improving (decreasing). It has decreased from 12,039.00 Cr. (Mar 2024) to ₹1,312.00 Cr., marking a decrease of 10,727.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹6,688.00 Cr.. The value appears to be improving (decreasing). It has decreased from 17,983.00 Cr. (Mar 2024) to ₹6,688.00 Cr., marking a decrease of 11,295.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹3,867.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,175.00 Cr. (Mar 2024) to ₹3,867.00 Cr., marking an increase of 692.00 Cr..
For CWIP, as of Sep 2024, the value is ₹231.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Mar 2024) to ₹231.00 Cr., marking an increase of 61.00 Cr..
For Investments, as of Sep 2024, the value is ₹24.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to ₹24.00 Cr., marking an increase of 7.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹2,567.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,620.00 Cr. (Mar 2024) to ₹2,567.00 Cr., marking a decrease of 12,053.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹6,688.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17,983.00 Cr. (Mar 2024) to ₹6,688.00 Cr., marking a decrease of 11,295.00 Cr..

Notably, the Reserves (2,936.00 Cr.) exceed the Borrowings (1,940.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	236	203	361	537	601	1,223	1,569	1,314	1,834	158
Cash from Investing Activity +	-439	-775	-1,136	-522	-702	-658	-333	-563	-951	-878
Cash from Financing Activity +	203	578	654	46	134	-675	-1,116	-686	-817	1,053
Net Cash Flow	-1	5	-122	61	33	-110	120	65	66	332

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-244.00	-435.00	505.00	442.00	347.00	630.00	-1.00	-4.00	-3.00	-4.00	441.00	574.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	95	86	83	93	79	84	93	100	86	72	285	23
Inventory Days	84	71	93	92	102	111	110	138	122	129	612	44
Days Payable	213	176	178	187	151	150	153	303	290	267	1,400	183
Cash Conversion Cycle	-34	-18	-2	-1	30	45	50	-65	-83	-66	-503	-116
Working Capital Days	82	61	69	68	57	59	57	40	38	40	129	297
ROCE %		18%	14%	6%	1%	7%	13%	12%	6%	10%	3%	4%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	37.88%	37.88%	37.88%	37.88%	41.88%	41.88%	41.88%	41.88%	41.88%	41.88%	41.88%	41.88%
FIIs	11.03%	11.44%	11.77%	42.49%	38.63%	38.82%	40.22%	41.00%	33.48%	27.08%	23.86%	22.62%
DIIs	8.64%	9.66%	8.99%	8.93%	8.93%	8.62%	7.64%	7.15%	13.70%	16.35%	20.91%	22.91%
Public	41.99%	40.57%	40.91%	10.25%	10.12%	10.26%	9.85%	9.61%	10.59%	14.38%	13.05%	12.30%
Others	0.46%	0.45%	0.45%	0.44%	0.43%	0.42%	0.41%	0.37%	0.35%	0.32%	0.30%	0.28%
No. of Shareholders	80,427	78,374	80,913	84,573	82,129	71,379	67,673	67,331	80,931	2,06,660	1,74,171	1,59,038

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Small Cap Fund - Regular Plan	16,630,886	2.57	736.17	16,630,886	2025-04-22 17:25:41	0%
Franklin India Smaller Companies Fund	4,465,529	1.67	197.67	4,465,529	2025-04-22 02:06:43	0%
HDFC Childrens Gift Fund - Regular Plan	3,600,000	1.89	159.35	3,600,000	2025-04-22 17:25:41	0%
Quant Small Cap Fund	1,758,485	0.5	77.84	1,758,485	2025-04-22 17:25:41	0%
Franklin India Opportunities Fund	1,489,839	2.65	65.95	1,489,839	2025-04-22 17:25:41	0%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund	1,242,100	1.54	54.98	1,242,100	2025-04-22 17:25:41	0%
ICICI Prudential Smallcap Fund	935,572	0.56	41.41	935,572	2025-04-22 17:25:41	0%
ICICI Prudential Value Discovery Fund	822,808	0.09	36.42	822,808	2025-04-22 17:25:41	0%
Sundaram Services Fund	639,329	0.88	28.3	639,329	2025-04-22 17:25:41	0%
Sundaram Small Cap Fund	609,647	0.88	26.99	609,647	2025-04-22 17:25:41	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	2.60	8.54	10.58	2.97	5.51
Diluted EPS (Rs.)	2.60	8.53	10.57	2.97	5.50
Cash EPS (Rs.)	8.87	25.12	24.96	15.93	18.03
Book Value[Excl.RevalReserv]/Share (Rs.)	100.70	89.81	90.15	77.14	66.95
Book Value[Incl.RevalReserv]/Share (Rs.)	100.70	89.81	90.15	77.14	66.95
Revenue From Operations / Share (Rs.)	74.05	238.89	206.21	173.19	174.94
PBDIT / Share (Rs.)	12.07	32.90	30.85	22.39	25.93
PBIT / Share (Rs.)	7.66	17.28	17.97	9.96	14.20
PBT / Share (Rs.)	5.46	10.69	12.80	4.05	6.61
Net Profit / Share (Rs.)	4.46	9.49	12.08	3.51	6.30
NP After MI And SOA / Share (Rs.)	2.59	8.51	10.58	2.97	5.54
PBDIT Margin (%)	16.29	13.77	14.96	12.92	14.82
PBIT Margin (%)	10.34	7.23	8.71	5.75	8.11
PBT Margin (%)	7.36	4.47	6.20	2.34	3.77
Net Profit Margin (%)	6.02	3.97	5.85	2.02	3.60
NP After MI And SOA Margin (%)	3.49	3.56	5.12	1.71	3.16
Return on Networth / Equity (%)	2.83	10.43	13.30	4.38	9.54
Return on Capital Employeed (%)	5.71	8.44	9.93	5.86	8.14
Return On Assets (%)	0.71	2.85	4.19	1.26	2.22
Long Term Debt / Equity (X)	0.09	0.32	0.37	0.52	0.65
Total Debt / Equity (X)	0.14	0.56	0.55	0.56	0.85
Asset Turnover Ratio (%)	0.22	0.18	0.14	0.09	0.12
Current Ratio (X)	1.25	1.06	1.15	1.14	1.10
Quick Ratio (X)	1.25	0.77	0.86	0.86	0.84
Interest Coverage Ratio (X)	5.46	4.99	5.97	3.79	3.60
Interest Coverage Ratio (Post Tax) (X)	2.96	2.44	3.34	1.59	1.93
Enterprise Value (Cr.)	21464.85	14334.72	12129.54	8918.86	7516.57
EV / Net Operating Revenue (X)	5.80	1.20	1.18	1.04	0.86
EV / EBITDA (X)	35.61	8.72	7.91	8.02	5.80
MarketCap / Net Operating Revenue (X)	5.53	1.01	0.95	0.79	0.54
Price / BV (X)	4.48	2.96	2.48	2.02	1.65
Price / Net Operating Revenue (X)	5.53	1.01	0.95	0.79	0.54
EarningsYield	0.01	0.03	0.05	0.02	0.05

After reviewing the key financial ratios for Aster DM Healthcare Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 2.60. This value is below the healthy minimum of 5. It has decreased from 8.54 (Mar 23) to 2.60, marking a decrease of 5.94.
For Diluted EPS (Rs.), as of Mar 24, the value is 2.60. This value is below the healthy minimum of 5. It has decreased from 8.53 (Mar 23) to 2.60, marking a decrease of 5.93.
For Cash EPS (Rs.), as of Mar 24, the value is 8.87. This value is within the healthy range. It has decreased from 25.12 (Mar 23) to 8.87, marking a decrease of 16.25.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.70. It has increased from 89.81 (Mar 23) to 100.70, marking an increase of 10.89.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.70. It has increased from 89.81 (Mar 23) to 100.70, marking an increase of 10.89.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 74.05. It has decreased from 238.89 (Mar 23) to 74.05, marking a decrease of 164.84.
For PBDIT / Share (Rs.), as of Mar 24, the value is 12.07. This value is within the healthy range. It has decreased from 32.90 (Mar 23) to 12.07, marking a decrease of 20.83.
For PBIT / Share (Rs.), as of Mar 24, the value is 7.66. This value is within the healthy range. It has decreased from 17.28 (Mar 23) to 7.66, marking a decrease of 9.62.
For PBT / Share (Rs.), as of Mar 24, the value is 5.46. This value is within the healthy range. It has decreased from 10.69 (Mar 23) to 5.46, marking a decrease of 5.23.
For Net Profit / Share (Rs.), as of Mar 24, the value is 4.46. This value is within the healthy range. It has decreased from 9.49 (Mar 23) to 4.46, marking a decrease of 5.03.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 2.59. This value is within the healthy range. It has decreased from 8.51 (Mar 23) to 2.59, marking a decrease of 5.92.
For PBDIT Margin (%), as of Mar 24, the value is 16.29. This value is within the healthy range. It has increased from 13.77 (Mar 23) to 16.29, marking an increase of 2.52.
For PBIT Margin (%), as of Mar 24, the value is 10.34. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 10.34, marking an increase of 3.11.
For PBT Margin (%), as of Mar 24, the value is 7.36. This value is below the healthy minimum of 10. It has increased from 4.47 (Mar 23) to 7.36, marking an increase of 2.89.
For Net Profit Margin (%), as of Mar 24, the value is 6.02. This value is within the healthy range. It has increased from 3.97 (Mar 23) to 6.02, marking an increase of 2.05.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.49. This value is below the healthy minimum of 8. It has decreased from 3.56 (Mar 23) to 3.49, marking a decrease of 0.07.
For Return on Networth / Equity (%), as of Mar 24, the value is 2.83. This value is below the healthy minimum of 15. It has decreased from 10.43 (Mar 23) to 2.83, marking a decrease of 7.60.
For Return on Capital Employeed (%), as of Mar 24, the value is 5.71. This value is below the healthy minimum of 10. It has decreased from 8.44 (Mar 23) to 5.71, marking a decrease of 2.73.
For Return On Assets (%), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 2.85 (Mar 23) to 0.71, marking a decrease of 2.14.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.32 (Mar 23) to 0.09, marking a decrease of 0.23.
For Total Debt / Equity (X), as of Mar 24, the value is 0.14. This value is within the healthy range. It has decreased from 0.56 (Mar 23) to 0.14, marking a decrease of 0.42.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.22. It has increased from 0.18 (Mar 23) to 0.22, marking an increase of 0.04.
For Current Ratio (X), as of Mar 24, the value is 1.25. This value is below the healthy minimum of 1.5. It has increased from 1.06 (Mar 23) to 1.25, marking an increase of 0.19.
For Quick Ratio (X), as of Mar 24, the value is 1.25. This value is within the healthy range. It has increased from 0.77 (Mar 23) to 1.25, marking an increase of 0.48.
For Interest Coverage Ratio (X), as of Mar 24, the value is 5.46. This value is within the healthy range. It has increased from 4.99 (Mar 23) to 5.46, marking an increase of 0.47.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.96. This value is below the healthy minimum of 3. It has increased from 2.44 (Mar 23) to 2.96, marking an increase of 0.52.
For Enterprise Value (Cr.), as of Mar 24, the value is 21,464.85. It has increased from 14,334.72 (Mar 23) to 21,464.85, marking an increase of 7,130.13.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.80. This value exceeds the healthy maximum of 3. It has increased from 1.20 (Mar 23) to 5.80, marking an increase of 4.60.
For EV / EBITDA (X), as of Mar 24, the value is 35.61. This value exceeds the healthy maximum of 15. It has increased from 8.72 (Mar 23) to 35.61, marking an increase of 26.89.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.53. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 23) to 5.53, marking an increase of 4.52.
For Price / BV (X), as of Mar 24, the value is 4.48. This value exceeds the healthy maximum of 3. It has increased from 2.96 (Mar 23) to 4.48, marking an increase of 1.52.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.53. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 23) to 5.53, marking an increase of 4.52.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Aster DM Healthcare Ltd as of April 28, 2025 is: 151.41

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 28, 2025, Aster DM Healthcare Ltd is Overvalued by 70.02% compared to the current share price 505.00

Intrinsic Value of Aster DM Healthcare Ltd as of April 28, 2025 is: 309.48

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 28, 2025, Aster DM Healthcare Ltd is Overvalued by 38.72% compared to the current share price 505.00

Last 5 Year EPS CAGR: 104.40%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Cash Conversion Cycle of -63.58, which is a positive sign. The company has shown consistent growth in sales (4.92 cr) and profit (275.92 cr) over the years.	The stock has a low average ROCE of 7.83%, which may not be favorable. The stock has a high average Working Capital Days of 83.08, which may not be favorable. The company has higher borrowings (3,012.69) compared to reserves (2,133.62), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aster DM Healthcare Ltd:
1. Net Profit Margin: 6.02%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 5.71% (Industry Average ROCE: 12.26%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.83% (Industry Average ROE: 11.45%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.96
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.25
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 87.2 (Industry average Stock P/E: 50.65)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.14
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Aster DM Healthcare Ltd. is a Public Limited Listed company incorporated on 18/01/2008 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L85110KA2008PLC147259 and registration number is 021703. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 2036.50 Cr. and Equity Capital is Rs. 499.52 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Bengaluru Kerala 560027	cs@asterdmhealthcare.com http://www.asterdmhealthcare.in

Management
Name	Position Held
Dr. Azad Moopen	Founder Chairman & Mng. Director
Ms. Alisha Moopen	Deputy Managing Director
Mr. Daniel Robert Mintz	Non Executive Director
Mr. T J Wilson	Non Executive Director
Mr. Shamsudheen Bin Mohideen Mammu Haji	Non Executive Director
Dr. James Mathew	Independent Director
Mr. Emmanuel David Gootam	Independent Director
Ms. Purana Housdurgamvijaya Deepti	Independent Director
Mr. Chenayappillil John George	Independent Director
Mr. Wayne Earl Keathley	Independent Director

FAQ

What is the intrinsic value of Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd's intrinsic value (as of 28 April 2025) is ₹151.41 — 70.02% lower the current market price of 505.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 25,238 Cr. market cap, FY2025-2026 high/low of ₹535/311, reserves of 2,936 Cr, and liabilities of 6,688 Cr.

What is the Market Cap of Aster DM Healthcare Ltd?

The Market Cap of Aster DM Healthcare Ltd is 25,238 Cr..

What is the current Stock Price of Aster DM Healthcare Ltd as on 28 April 2025?

The current stock price of Aster DM Healthcare Ltd as on 28 April 2025 is 505.

What is the High / Low of Aster DM Healthcare Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Aster DM Healthcare Ltd stocks is ₹535/311.

What is the Stock P/E of Aster DM Healthcare Ltd?

The Stock P/E of Aster DM Healthcare Ltd is 87.2.

What is the Book Value of Aster DM Healthcare Ltd?

The Book Value of Aster DM Healthcare Ltd is 68.8.

What is the Dividend Yield of Aster DM Healthcare Ltd?

The Dividend Yield of Aster DM Healthcare Ltd is 0.79 %.

What is the ROCE of Aster DM Healthcare Ltd?

The ROCE of Aster DM Healthcare Ltd is 4.48 %.

What is the ROE of Aster DM Healthcare Ltd?

The ROE of Aster DM Healthcare Ltd is 3.13 %.

What is the Face Value of Aster DM Healthcare Ltd?

The Face Value of Aster DM Healthcare Ltd is 10.0.